Inovio reports second quarter 2021 financial results

Plymouth meeting, pa., aug. 9, 2021 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on rapidly bringing to market precisely designed dna medicines to treat and protect people from infectious diseases, cancer, and hpv-associated diseases, today reported financial results for the quarter ended june 30, 2021.
INO Ratings Summary
INO Quant Ranking